Skip to main content
Log in

Synthesis, structure–activity relationships, and bioactivity evaluation of 6-bromo-quinazolinone derivatives

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

6-Bromo-quinazolinone derivatives were prepared and evaluated for the ability to inhibit cyclooxygenase-2 (COX-2). An extensive structure–activity relationship work was carried out, thus some potent and selective COX-2 inhibitors were identified. The key compound isothiocyanate was prepared through a simple and ecological method using di-2-pyridyl thionocarbonate in substitution of the thiophosgene, a potential air pollutant. The cyclization reaction of intermediate derivatives was developed through the methods reporting by Wamhoff. The anti-inflammatory activity of the derivatives (512) was evaluated by determining (by Western blot) the expression of cyclooxygenase (COX)-2, of inducible NO synthase (iNOS) and of intercellular adhesion molecule-1 (ICAM-1). The biological assays showed that the derivatives 7, 9, 10, 12 act as potent inhibitors of COX-2, iNOS, and ICAM-1 expression in human keratinocytes NCTC-2544 cells. This work showed that the new derivatives could be used as a novel class of anti-inflammatory agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Scheme 2
Scheme 3
Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Abbas ES, Awadallah MF, Ibrahim AN, Said GE, Kamel MG (2012) New quinazolinone–pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies. Eur J Med Chem 53:141–149. doi:10.1016/j.ejmech.2012.03.050

    Article  CAS  PubMed  Google Scholar 

  • Albanesi C, Pastore S, Fanales-Belasio E, Girolimoni G (1998) Cetirizine and hydrocortisone differentially regulate ICAM-1 expression and chemokine release in cultured human keratinocytes. Clin Exp Allergy 28:101–109

    Article  CAS  PubMed  Google Scholar 

  • Allison MC, Howatson AG, Torrence CJ, Lee FD, Russel RI (1992) Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. New Engl J Med 327:749–754. doi:10.1056/NEJM199209103271101

    Article  CAS  PubMed  Google Scholar 

  • Amin MK, Kamel MM, Anwar MM, Khedr M, Syam MY (2010) Synthesis, biological evaluation and molecular docking of novel series of spiro [(2H,3H) quinazoline-2,10-cyclohexan]-4(1H)-one derivatives as anti-inflammatory and analgesic agents. Eur J Med Chem 45:2117–2131. doi:10.1016/j.ejmech.2009.12.078

    Article  CAS  PubMed  Google Scholar 

  • Aubock J, Romani N, Grubauer G, Fntsch P (1986) HLA-DR expression by keratinocytes is a common feature of diseased skin. Br J Dermatol 114:467–472

    Article  Google Scholar 

  • Barker JNWN, Markey AC, Allen MH, MacDonald DM (1989) Keratmocyte expression of OKM5 antigen in inflammatory cutaneous disease. Br J Dermatol 120:613–618

    Article  CAS  PubMed  Google Scholar 

  • Barone M, Graziano ACE, Marrazzo A, Gemmellaro P, Santagati A, Cardile V (2013) Synthesis and biological evaluation of new benzo-thieno[3,2-d]pyrimidin-4-one sulphonamide thio-derivatives as potential selective cyclooxygenase-2 inhibitors. Mol Divers 17:445–458. doi:10.1007/s11030-013-9443-0

    Article  CAS  PubMed  Google Scholar 

  • Bekhit AA, Abdel-Aziem T (2004) Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents. Bioorg Med Chem 12(8):1935–1945. doi:10.1016/j.bmc.2004.01.037

    Article  CAS  PubMed  Google Scholar 

  • Bissonnette EY (1996) Histamine inhibits tumor necrosis factor a release mast cells through H2 and H3 receptors. Am J Respir Cell Mol Biol 14:620–626. doi:10.1165/ajrcmb.14.6.8652190

    Article  CAS  PubMed  Google Scholar 

  • Cardile V, Frasca G, Rizza L, Rapisarda P, Bonina F (2010) Antiinflammatory effects of a red orange extract in human keratinocytes treated with interferon-gamma and histamine. Phytother Res 24(3):414–418. doi:10.1002/ptr.2973

    Article  CAS  PubMed  Google Scholar 

  • Carlos D, Sá-Nunes A, de Paula L, Matias-Peres C, Jamur MC, Oliver C, Serra MF, Martins MA, Faccioli LH (2006) Histamine modulates mast cell degranulation through an indirect mechanism in a model IgE- mediated reaction. Eur J Immunol 36:1494–1503. doi:10.1002/eji.200535464

    Article  CAS  PubMed  Google Scholar 

  • Caron G, Delneste Y, Roelandts E, Duez C, Herbault N, Magistrelli G, Bonnefoy JY, Pestel J, Jeannin P (2001) Histamine induces CD86 expression and chemokine production by human immature dendritic cells. J Immunol 166:6000–6006. doi:10.4049/jimmunol.166.10.6000

    Article  CAS  PubMed  Google Scholar 

  • Carpenter RD, Lam KS, Kurth MJ (2007) Microwave-mediated heterocyclization to benzimidazo[2,1-b]quinazolin-12(5H)-ones. J Org Chem 72(1):284–287. doi:10.1021/jo0618066

    Article  CAS  PubMed  Google Scholar 

  • Chun KS, Kim SH, Song YS, Surh YJ (2004) Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin. Carcinogenesis 25(5):713–722

    Article  CAS  PubMed  Google Scholar 

  • Clive DM, Stoff JS (1984) Renal syndromes associated with nonsteroidal anti-inflammatory drugs. New Engl J Med 310:563–572. doi:10.1056/NEJM198403013100905

    Article  CAS  PubMed  Google Scholar 

  • Cuzzocrea S, Mazzon E, Serraino I, Dugo L, Centorrino T, Ciccolo A, Sautebin L, Caputi AP (2001) Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats. Eur J Pharmacol 431(1):91–102

    Article  CAS  PubMed  Google Scholar 

  • Dannhart G, Kiefer W (2001) Cyclooxygenase inhibitors-current status and future prospects. Eur J Med Chem 36:109–126. doi:10.1016/S0223-5234(01)01197-7

    Article  Google Scholar 

  • DeWitt DL, Smith WL (1988) Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci USA 85:1412–1416

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Dinakaran M, Selvam P, Declercq E, Sridhar SK (2003) Synthesis, antiviral and cytotoxic activity of 6-bromo-2,3-disubstituted-4(3H)-quinazolinones. Biol Pharm Bull 26:1278–1282. doi:10.1248/bpb.26.1278

    Article  CAS  PubMed  Google Scholar 

  • Dohlsten M, Kalland T, Sjoergen HO, Carlson R (1988) Histamine inhibits interleukin 1 production by lipopolysaccharide-stimulated human peripheral blood monocytes. Scand J Immunol 27:527–532

    Article  CAS  PubMed  Google Scholar 

  • Ferreri NR, An SJ, McGiff JC (1999) Cyclooxygenase-2 expression and function in the medullary thick ascending limb. Am J Physiol 277:F360–F368

    CAS  PubMed  Google Scholar 

  • Fitzgerald GA, Patrono C (2001) The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 345:433–442. doi:10.1056/NEJM200108093450607

    Article  CAS  PubMed  Google Scholar 

  • Gassani AB, Rezende MR, Lima PP, Alves LD, Dosreis GW, Bakhle SY, Francischi NJ (2010) Is the sulphonamide radical in the celecoxib molecule essential for its analgesic activity? Pharmacol Res 62:439–443. doi:10.1016/j.phrs.2010.06.007

    Article  CAS  PubMed  Google Scholar 

  • Giustizieri ML, Albanesi C, Fluhr J, Gisondi P, Norgauer J, Girolomoni G (2004) H1 histamine receptor mediates inflammatory responses in human keratinocytes. J Allergy Clin Immunol 114:1176–1182

    Article  CAS  PubMed  Google Scholar 

  • Griffiths CEM, Voorhees JJ, Nickoloff BJ (1989) Characterization of intercellular adhesion molecule-l and HLA-DR m normal and inflamed skin: modulation by interferon-gamma and tumor necrosis factor. J Am Acad Derrnatol 20:617–629

    Article  CAS  Google Scholar 

  • Grossman M, Kruegar J, Younsh D et al (1989) Interleukm 6 is expressed m high levels in psoriatic skin and stimulates proliferation of cultured human keratmocytes. Proc Natl Acad Sci USA 86:6367–6371

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD (1994) Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 94:2504–2510. doi:10.1172/JCI117620

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hawkey C, Laine L, Simon T, Beaulieu A, Maldonado CJ, Acevedo E, Shahane A, Quan H, Bolognese J, Mortensen E (2000) Comparison of the effect of rofecoxib (a cyclooxygenase-2 inhibitor), ibuprofen and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The rofecoxib osteoarthritis endoscopy multinational study group. Arthritis Rheum 43:370–377. doi:10.1002/1529-0131(200002

    Article  CAS  PubMed  Google Scholar 

  • Hla T, Neilson K (1992) Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 89:7384–7388

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hodgkins JE, Ettilinger MG (1956) The synthesis of isothiocyanates from amines. J Org Chem 21:404–405. doi:10.1021/jo01110a006

    Article  CAS  Google Scholar 

  • Jaiswal M, Khadikar VP, Supuran TC (2004) Topological modeling of lipophilicity, diuretic activity, and carbonic inhibition activity of benzenesulfonamides: a molecular connectivity approach. Bioorg Med Chem Lett 14:5661–5666. doi:10.1016/j.bmcl.2004.08.051

    Article  CAS  PubMed  Google Scholar 

  • Kini GS, Grover G (2006) Synthesis and evaluation of new quinazolone derivatives of nalidixic acid as potential antibacterial and antifungal agents. Eur J Med Chem 41:256–262. doi:10.1016/j.ejmech.2005.09.002

    Article  PubMed  Google Scholar 

  • Kniss DA (1999) Cyclooxygenases in reproductive medicine and biology. J Soc Gynecol Invest 6:285–292

    Article  CAS  Google Scholar 

  • Krouwels FH, Hol BE, Lutter R, Bruinier B, Bast A, Jansen HM, Out TA (1998) Histamine affects interleukin-4, interleukin-5, and interferon-g production by human T cell clones from the airways and blood. Am J Respir Cell Mol Biol 18:721–730. doi:10.1165/ajrcmb.18.5.2909

    Article  CAS  PubMed  Google Scholar 

  • Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR (1991) TIS10, a phorbol ester tumor promoter inducible mRNA from swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266:12866–12872. http://www.jbc.org/content/266/20/12866

  • Lagier B, Lebel B, Bousquet J, Péne J (1997) Different modulation by histamine of IL-4 and interferon-g (IFN-g) release according to the phenotype of human Th0, Th1 and Th2 clones. Clin Exp Immunol 108:545–551. doi:10.1046/j.1365-2249.1997.3791276.x

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lemura R, Manabe H, Todayaki S (1989) Bioisosteric transformation of H1-antihistaminic benzimidazole derivatives. Chem Pharm Bull 37:2723–2726

    Article  Google Scholar 

  • Liu J, Wilson JC, Ye P, Sprague K, Sargent K, Si Y, Beletsky G, Yohannes D, Chung S (2006) Privileged structure based quinazolinone natural product-templated libraries: identification of novel tubulin polymerization inhibitors. Bioorg Med Chem Lett 16:686–690. doi:10.1016/j.bmcl.2005.10.022

    Article  CAS  PubMed  Google Scholar 

  • Marnett LJ, DuBois RN (2002) COX-2: a target for colon cancer prevention. Annu Rev Pharmacol Toxicol 42:55–80. doi:10.1146/annurev.pharmtox.42.082301.164620

    Article  CAS  PubMed  Google Scholar 

  • Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC, Seibert K (1994) Selective inhibition of inducible cyclooxygenase-2 in vivo is anti-inflammatory and nonulcerogenic. Proc Natl Acad Sci USA 91:3228–3232

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Miao XP, Li JS, Ouyang Q, Hu RW, Zhang Y, Li HY (2014) Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease. Cochrane Database Syst Rev. doi:10.1002/14651858.CD007744.pub2

    PubMed  Google Scholar 

  • Nickoloff BJ (1988) The role of gamma interferon in epidermal traffickmg of lymphocytes with emphasis on molecular and cellular adhesion events. Arch Dermatoll 124:1835–1843. doi:10.1001/archderm.1988.01670120051010

    Article  CAS  Google Scholar 

  • Nickoloff BJ, Mitra RS, Elder JT, Fisher GJ, Voorhees JJ (1989) Decreased growth inhibition by recombinant gamma interferon is associated with increased production of transforming growth factor alpha m keratinocytes cultured from psonatic lesions. Br J Dermatoll 121:161–174

    Article  CAS  Google Scholar 

  • O’Sullivan MG, Huggins EM Jr., Mccall CE (1993) Lipopolysaccharide—induced expression of prostaglandin H synthase-2 in aveolar macrophages is inhibited by dexamethasone but not by aspirin. Biochem Biophys Res Commun 191:1294–1300. doi:10.1006/bbrc.1993.1358

    Article  PubMed  Google Scholar 

  • Patrono C, Patrignani P, Garcìa Rodriguez LA (2001) Cyclooxygenase—selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. J Clin Invest 108:7–13. doi:10.1172/JCI13418

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rocca B, Spain LM, Pure E, Langenbach R, Patrono C, FitzGerald GA (1999) Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development. J Clin Invest 103:1469–1477. doi:10.1172/JCI6400

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Roh GS, Yi CO, Cho YJ, Jeon BT, Nizamudtinova IT, Kim HJ, Kim JH, Oh YM, Huh JW, Lee JH, Hwang YS, Lee SD, Lee JD (2010) Anti-inflammatory effects of celecoxib in rat lungs with smoke-induced emphysema. Am J Physiol Lung Cell Mol Physiol 299(2):L184–L191. doi:10.1152/ajplung.00303.2009

    Article  CAS  PubMed  Google Scholar 

  • Salvemini D, Manning PT, Zeifel BS, Seibert K, Curie MG, Needleman P, Masferrer JL (1995) Dual inhibition of nitric oxide and prostaglandin production contributes to the anti-inflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 96:301–308. doi:10.1172/JCI118035

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sirois J, Ménard G, Moses AS, Bissonnette EY (2000) Importance of histamine in the cytokine network in the lung through H2 and H3 receptors: stimulation of IL-10 production. J Immunol 164:2964–2970. doi:10.4049/jimmunol.164.6.2964

    Article  CAS  PubMed  Google Scholar 

  • Smith WL, Langenbach R (2001) Why there are two cyclooxygenase isozymes. J Clin Invest 12:1491–1495. doi:10.1172/JCI13271

    Article  Google Scholar 

  • Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A, Talley JJ, Masferrer JL, Seibert K, Isakson PC (1998) Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 95:13313–13318

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sperotto E, van Klink G, de Vriev J, van Koten G (2008) Ligand free copper-catalyzed C–S coupling of aryl iodides and thiols. J Org Chem 73:5625–5628. doi:10.1021/jo800491k

    Article  CAS  PubMed  Google Scholar 

  • Staszak C, Goodwin JS (1980) Is prostaglandin a mediator for the inhibitory action of histamine, hydrocortisone, and isoproterenol? Cell Immunol 54:351–361

    Article  CAS  PubMed  Google Scholar 

  • Tiwari AK, Mishra AK, Bajpai A, Mishra P, Sharma RK, Pandey VK, Singh VK (2006) Synthesis and pharmacological study of novel pyrido-quinazolone analogues as anti-fungal, antibacterial, and anticancer agents. Bioorg Med Chem Lett 16:4581–4585. doi:10.1016/j.bmcl.2006.06.015

    Article  CAS  PubMed  Google Scholar 

  • Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231:232–235

    Article  CAS  PubMed  Google Scholar 

  • Wamhoff H, Lichtenthaler L (1978) Heterocyclische β-enaminoester, 22: pyrido[2,3-d]pyrimidine aus 2-amino-3-ethoxycarbonyl-1,4,5,6-tetrahydropyridin und isocyanaten, isothiocyanaten, imidsäureestern, formamid und lactimethern. Chem Ber 111:2297–2306

    Article  CAS  Google Scholar 

  • Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF (1993) Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11:371–386. doi:10.1016/0896-6273(93)90192-T

    Article  CAS  PubMed  Google Scholar 

  • Zambre AP, Ganure AL, Shinde DB, Kulkarni VM (2007) Perspective assessment of COX-1 and COX-2 selectivity of nonsteroidal anti-inflammatory drugs from clinical practice: use of genetic function approximation. J Chem Inf Model 47:635–643. doi:10.1021/ci6004367

    Article  CAS  PubMed  Google Scholar 

  • Zayed MF, Hassan MH (2014) Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents. Saudi Pharm J 22:157–162. doi:10.1016/j.jsps.2013.03.004

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mariarita Barone.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Barone, M., Pistarà, V., Frasca, G. et al. Synthesis, structure–activity relationships, and bioactivity evaluation of 6-bromo-quinazolinone derivatives. Med Chem Res 24, 2461–2475 (2015). https://doi.org/10.1007/s00044-014-1311-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-014-1311-7

Keywords

Navigation